- Report ID: BMRC 290 | Number of pages: 200 | Publish Date: Dec 2019
Status: Published | Category: Healthcare | Delivery Timeline:
Esoteric Market Increasing burden of chronic diseases due to rapidly developing geriatric population and technological advancement in research and development are some of the key drivers of Esoteric Market.
Esoteric Testing testing is usually referred to typically in specialized areas of molecular diagnostics such as endocrinology, genetics, microbiology, serology, immunology, molecular biology, oncology and toxicology. Molecular diagnostics is the fastest growing area in the Esoteric Testing clinical testing. So during the study of global Esoteric Testing market, we have considered instruments and consumables to analyze the market.
Global Esoteric Testing market report is segmented on the basis of test type, technology type, lab type and by regional & country level. Based upon test type, global Esoteric Testing market is classified as infectious diseases testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing and others. Based upon technology type, global Esoteric Testing market is classified as ELISA enzyme-linked immune sorbent assay (ELISA), PCR, CLIA (chemi-luminescence immunoassay), Mass Spectroscopy Flow cytometry, Radioimmunoassay and others. Based upon lab type, global Esoteric Testing market is classified as clinical testing labs, hospital labs and research labs.
The regions covered in this Esoteric Testing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Esoteric Testing is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Esoteric Testing market reports covers prominent players like Laboratory Corporations of America Holdings, Quest Diagnostics Inc. OPKO Health Inc., ARUP Laboratories, Mayo Medical Laboratories, Myriad Genetics Inc., Genomic Health, Foundation Medicine, Miraca Holdings Inc., Fulgent Genetics Inc., Stanford Health Care, Invitae Corporation and others.
According to the National Council on Aging, presently about 80 percent of older adults have at least one chronic disease and 68 percent have at least two. Therefore, increasing burden of chronic diseases due to the rising geriatric population is the major key driver for growth of global Esoteric Testing market. The other drivers include rising demand for early diagnosis, rising prevalence of infectious diseases, growing awareness about personalized medicine, increasing government funding for the research and development of new innovative Esoteric Testing tests. However, high price associated with Esoteric Testing testing equipments and procedures may affect the growth of Global Esoteric Testing Market. Nonetheless, untapped market and technological advancement may generate new opportunities in forecast period.
By Test Type
By Lab Type
Interested in this report?
Esoteric Market By Test Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetic Testing, Toxicology Testing, Microbiology), By Technology Type (ELISA enzyme-linked immunosorbent assay, PCR, CLIA, Mass Spectroscopy, Flow cytometry), By Lab Type (Clinical testing labs, Hospital Labs, Research Labs), Industry Analysis, Trends, and Forecast 2019